TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 8.49
+0.01 (0.12%)
May 28, 2026, 11:56 AM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 3.26 billion as of May 27, 2026. Its market cap has decreased by -73.34% in one year.
Market Cap
3.26B
Enterprise Value
3.02B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.49
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 3.26B, a decrease of -35.79%. That is a compound annual growth rate of -22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 3.26B | -34.53% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 3.88B |
| Shandong Boan Biotechnology | 3.77B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.49B |
| BioDlink International Company | 3.45B |
| Clover Biopharmaceuticals | 3.32B |
| Jiangsu Recbio Technology | 3.18B |
| Medtide | 3.16B |